key: cord-0880216-xv42jvd6 authors: Spencer, Julie; Shutt, Deborah P; Moser, Sarah K; Clegg, Hannah; Wearing, Helen J; Mukundan, Harshini; Manore, Carrie A title: Epidemiological parameter review and comparative dynamics of influenza, respiratory syncytial virus, rhinovirus, human coronavirus, and adenovirus date: 2020-02-05 journal: nan DOI: 10.1101/2020.02.04.20020404 sha: e3f19f88e7e3d1279b4d93e4db041e44a8d35dbb doc_id: 880216 cord_uid: xv42jvd6 Influenza-like illness (ILI) accounts for a large burden of annual morbidity and mortality worldwide. A finer-grained knowledge of the parameters and dynamics of the viruses commonly underlying ILI is needed for modeling, diagnostic, and intervention efforts. We conducted an extensive literature review for epidemiological parameter values for influenza, respiratory syncytial virus (RSV), rhinovirus, human coronavirus (HCoV), and adenovirus. We also developed a deterministic SEIR model for ILI, and derived an expression for R0. We here report ranges and means for parameters for these five common viruses. Influenza-like illness (ILI) accounts for a large burden of annual morbidity and mortality worldwide (WHO 2020) . Despite this, diagnostic testing for specific viruses underlying ILI is relatively rare (CDC 2019) . This results in a lack of information about the pathogens that make between 9 million and 49 million people sick every year in the United States alone (CDC 2020 ). Yet knowledge of the specific diseases is necessary for timely treatment to prevent unnecessary suffering and death (Nguyen 2016 , Van Asten et al. 2012 , Pawelek et al. 2015 . ILI is defined by the CDC as fever of 100 • F and a cough and/or a sore throat without a known cause other than influenza (CDC 2020) . Defining ILI as a cluster of symptoms rather than a specific disease or diseases is necessary for keeping track of case counts, as well as for important analysis and forecasting (Osthus and Moran 2019). However, the cluster of symptoms known as ILI is caused by many under-lying pathogens (Taylor 2017 , Galindo-Fraga 2013 . Positive diagnosis is a prerequisite for accurate treatment. To respond to this need and to gain a finer-grained understanding of ILI that will contribute to a practical foundation for advances in diagnostics and interventions, we here review the literature for parameter values. We then compare the dynamics of five common upper respiratory viruses implicated in ILI: influenza, respiratory syncytial virus (RSV), rhinovirus, human coronavirus (HCoV), and adenovirus. We conducted a literature review to establish plausible ranges for model parameters, and developed a deterministic system of ordinary differential equations to model the general dynamics of these five viruses. 2 Results of Parameter Literature Review 2.1 ILI Viruses studies. R 0 values were estimated from modeling studies. In one case, (SARS-hCoV), we included an estimate for the infectious period, since values were lacking in the literature (Chowell 2004) . We also searched the literature for the contribution made by each of the five viruses to the total viral community in people with ILI. Across ten study populations, at least one virus was identified in an average of 62% of individuals with ILI symptoms. Out of these 62% of patients with ILI in whom viruses have been identified, In view of the current outbreak of novel coronavirus 2019-nCoV, and given the need for plausible parameters for modeling efforts, we conducted an in-depth literature review for human coronavirus. 2019-nCoV has been identified as a member of genus betacoronavirus, along with SARS and MERS (WHO 2020) . Until the genomes of 2019-nCoV have been further characterized, it seems reasonable to suspend assumptions about the epidemiological behavior of the novel virus, and to include all known strains in the parameter sets. Thus, our review includes values for strains 229E, NL63, OC43, HKU1, SARS, and MERS. Means have been collected when possible; when not available, medians have been recorded. Information on the studies, the strains, the sample sizes, and the references is available on pages 26-27 of this paper. We included values for R 0 only for SARS and MERS, and attempted to include them only for the period before large-scale interventions were implemented, since R 0 is defined as the average number of sec-ondary infections produced when one infected individual is introduced into a fully susceptible population (K. Deitz, 1975) . Since the seasonal strains of human coronavirus are endemic in the world, there is, by definition, no fully susceptible population for 229E, NL63, OC43, or HKU1 in which R0 may be assessed. Results of our review for human coronavirus include the following mean values: an incubation period of 5.01 days, an infectious period of 15.2 days, a hospitalization period of 4.96 days, a hospitalized proportion of 0.188, a case fatality proportion of 0.147, and an R 0 of 3.7. The model diagram ( Fig.1) illustrates the progression of influenza-like illness (ILI) in a human population of a hypothetical small city containing 10,000 individuals. We assume density-dependence, that is, for a fixed population of 10,000 humans with negligible migration, the contact rate for individuals remains constant. The total population (N) consists of seven classes: susceptible (S), exposed but not infectious (E), first infectious class (I 1 ), second infectious class (I 2 ), hospitalized (H), recovered (R), or dead (D). Individ-uals are considered susceptible until they contact an infectious individual from (I 1 ), (I 2 ), or (H). Given contact with an infectious individual, transmission takes place with some probability. After transmission of the virus has occurred, susceptible people move to the exposed class (E), where they spend a number of days equal to the mean period of time between infection and the onset of infectiousness (the latent period). We assume here that the latent period equals the incubation period, or the mean period of time between exposure to the virus and the onset of symptoms. After the latent period, they move to the first infectious class (I 1 ). The mean duration of the first infectious period differs according to the underlying virus. Symptoms worsen for some proportion of the first infectious class, who enter the hospital (H), where they remain infectious. Individuals who do not enter the hospital remain ill outside the hospital for the duration of the second infectious period (I 2 ). From (I 2 ), the length of which differs according to the underlying virus, where we assume that the progression of the illness is not severe, individuals recover. The duration of hospitalization differs according to the underlying virus. From the hospital, individuals either recover (R) or die (D). We assume that hospitalized individuals have 75% less contact with susceptible individuals, which results in 75% reduced transmission during hospitalization. We further assume that recovered individuals (R) gain full immunity to the virus causing the illness. (1) From the initially infectious state, individuals progress to hospital or continued non-hospitalized infectious state. (2) From the non-hospitalized infectious state, individuals progress to recovery. (3) From the hospitalized state, individuals progress to death or recovery. (4) Everyone who recovers gains full immunity. (5) Total infected population = E + I 1 + I 2 + H. (6) Total infectious population = I 1 + I 2 + H. (7) The viruses operate independently. (8) The population is homogeneously mixed. (9) No demographics are included. (10) The transmission rate for each virus is calculated from the expression for R 0 below, using the mean R 0 values from the literature. The equations governing common upper respiratory virus dynamics are given by The total population is N = S + E + I 1 + I 2 + H + R + D. Parameters We assume that the stable population, representing a hypothetical small city, is N = 10000. We further assume that the initial value for the Susceptible population is S 0 = 10000. In the disease-free state, all infected classes are zero,that is, E = I 1 = I 2 = H = 0. Substituting and setting the derivatives equal to zero, it is evident that in the disease-free state, the other state variables R and D will continue to contain zero individuals, and that the Susceptible class S will remain equal to the total population N, as follows. Additionally, if we set any one of E, I 1 , I 2 , or H to zero, the other three state variables representing infected classes must also be zero. In this case, N=S=10000. Thus, where x = (S, E, I 1 , I 2 , H, R, D) denotes solutions of the system, x df e = (10000, 0, 0, 0, 0, 0, 0) represents the disease-free equilibrium for the system. Assuming a homogeneously mixed population, the basic reproductive number (R 0 ) is defined as the average number of secondary infections produced when one infected individual is introduced into a fully susceptible population (K. Dietz, 1993) . Four compartments, latently infected individuals (E), symptomatic and infected individuals (I 1 ), symptomatic and infected and non-hospitalized individuals (I 2 ), and hospitalized individuals (H), together characterize the total infected population for the ILI virus system. To calculate R 0 for this system, we derive the next generation matrix (Van den Driessche and Watmough 2002). Method: 1. Derive the matrix for the transmission term describing everyone entering (E): the "F" matrix; 2. Derive the matrix for the transition terms describing everyone transitioning between infected classes (E, I 1 , I 2 , H): the "V" matrix; 3. Next Generation Matrix (NGM) = (F )(V −1 ); 4. The largest dominant eigenvalue or spectral radius of the NGM = R0 for the system. The transmission term for the system is βS(I 1 + I 2 + cH) The transmission terms for the system are (−γ 1 E), (γ 1 E − γ 2 I 1 ), (γ 2 (1 − p 1 )I 1 − γ 4 I 2 ), (γ 2 p 1 I 1 − γ 3 H). The next generation matrix is The spectral radius, or the largest positive eigenvalue of the next generation matrix, is the basic reproductive number of the system at the disease-free equilibrium, as follows. This expression for the basic reproductive number (R 0 ) depends on the parameters β, c, p 1 , γ 2 , γ 3 and γ 4 , and on the initial conditions for the state variables. β is clearly directly proportional to R 0 . R 0 = P(arriving at I 1 )(R 0 while in I 1 ) + P( arriving at I 2 )(R 0 while in I 2 ) + P(arriving at H)(R 0 while in H) There are several limitations to this study. First, the model is not age-structured. Second, the assumption that the latent period equals the incubation period may result in an overestimation of the latent period. This is because the beginning of the true infectious period may occur before the onset of symptoms; however, this is difficult to measure and is not generally reported in the studies that report values for the incubation period. Third, a single mortality rate has been modeled for the hospitalized infected and non-hospitalized infected classes. Fourth, many of the studies that generated parameter values evaluated populations treated at clinics or admitted at hospitals. However, a significant proportion of illness and death may occur outside of hospitals and clinics (see Cohen et al. 2017 . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint . . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint . https://doi.org/10.1101/2020.02.04.20020404 doi: medRxiv preprint WHO, "Influenza Burden of Disease," https://www.who.int/influenza/surveillance monitoring/bod/en/. Accessed on 1/28/2020. . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint Taylor, S., Lopez, P., Weckx, L., Borja-Tabora, C., Ulloa-Gutierrez, R., Lazcano-Ponce, E., Kerdpanich, A., Weber, M.A.R., de Los Santos, A.M., Tinoco, J.C. and Safadi, M.A.P., 2017. Respiratory viruses and influenzalike illness: epidemiology and outcomes in children aged 6 months to 10 years in a multi-country population sample. Journal of Infection J.H., Woo, H.T., Oh, H.S., Moon, S.M., Choi, J.Y., Lim, J.U., Kim, D., Byun, J., Kwon, S.H., Kang, D. Lessler, J., Reich, N.G., Brookmeyer, R., Perl, T.M., Nelson, K.E. and Cummings, D.A., 2009 . Incubation periods of acute respiratory viral infections: a systematic review. Human coronavirus NL63 infection in Canada Dynamically modeling SARS and other newly emerging respiratory illnesses: past, present, and future Infectious Diseases of Bhutan 2010 edition Estimates of the reproduction number for seasonal, pandemic, and zoonotic influenza: a systematic review of the literature Infections by human coronavirus-NL in hospitalized children. The Pediatric infectious disease journal Contribution of respiratory pathogens to influenza-like illness consultations Effects of a" new" human respiratory virus in volunteers Rates of respiratory virus-associated hospitalization in children aged¡ 5 years in rural northern India Use of a multiplex PCR/RT-PCR approach to assess the viral causes of influenza-like illnesses in Cambodia during three consecutive dry seasons RSV Transmission Influenza Surveillance System: Purpose and Methods Multisite virological influenza surveillance in India Estimation of basic reproduction number of the Middle East respiratory syndrome coronavirus (MERS-CoV) during the outbreak in South Korea Virologically confirmed population-based burden of hospitalization caused by respiratory syncytial virus, adenovirus, and parainfluenza viruses in children in Hong Kong Human coronavirus NL63 infection and other coronavirus infections in children hospitalized with acute respiratory disease in Hong Kong The reproduction number of seasonal influenza epidemics in Brazil Seasonal influenza in the United States, France, and Australia: transmission and prospects for control In-and out-of-hospital mortality associated with seasonal and pandemic influenza and respiratory syncytial virus in South Africa Experimental transmission of minor respiratory illness to human volunteers by filter-passing agents. I. Demonstration of two types of illness characterized by long and short incubation periods and different clinical features Viral shedding and antibody response in 37 patients with Middle East respiratory syndrome coronavirus infection Correlated studies of a recombinant influenza-virus vaccine. III. Protection against experimental influenza in man Estimation of the serial interval of influenza Effect of vaccines and antivirals during the major 2009 A (H1N1) pandemic wave in Norway-and the influence of vaccination timing Influenza-like illnesses in Senegal: not only focus on influenza viruses Quantitative rhinovirus shedding patterns in volunteers The estimation of the basic reproduction number for infectious diseases Rhinovirus neutralizing antibody in tears, parotid saliva, nasal secretions and serum The influenza season 2016/17 in Bucharest, Romania-surveillance data and clinical characteristics of patients with influenza-like illness admitted to a tertiary infectious diseases hospital Replication of respiratory viruses, particularly influenza virus, rhinovirus, and coronavirus in HuH7 hepatocarcinoma cell line Characterization of viral agents causing acute respiratory infection in a San Francisco University Medical Center Clinic during the influenza season Viruses associated with acute respiratory infections and influenza-like illness among outpatients from the Influenza Incidence Surveillance Project Clinical characteristics and outcomes of influenza and other influenza-like illnesses in Mexico City Epidemiological surveillance and comparative analysis of patients with influenza like illness and other respiratory viruses Epidemiology of viral respiratory infections in Australian workingage adults (20-64 years Molecular diagnosis of respiratory virus infections Contribution of respiratory pathogens to influenzalike illness consultations A prospective, communitybased study on virologic assessment among elderly people with and without symptoms of acute respiratory infection Use of a multiplex PCR/RT-PCR approach to assess the viral causes of influenza-like illnesses in Cambodia during three consecutive dry seasons Influenza-like illness incidence is not reduced by influenza vaccination in a cohort of older adults, despite effectively reducing laboratoryconfirmed influenza virus infections Influenza-like illness incidence is not reduced by influenza vaccination in a cohort of older adults, despite effectively reducing laboratoryconfirmed influenza virus infections Mortality attributable to 9 common infections: significant effect of influenza A, respiratory syncytial virus, influenza B, norovirus, and parainfluenza in elderly persons Population-based surveillance for hospitalizations associated with respiratory syncytial virus, influenza virus, and parainfluenza viruses among young children *Rhinovirus included other enteroviruses in many studies children w/ HcoV-NL hospitalized for acute respiratory tract infections 12 mean duration of hospitalization ≤3 years 4.9 days Boivin, G., Baz, M., Côté, S., Gilca, R., Deffrasnes, C., Leblanc, É., Bergeron, M.G., Déry, P. and De Serres, G., 2005 Broor, S., Gunasekaran, P., Potdar, V.A., Krishnan, A., Chawla-Sarkar, M., Biswas, D., Abraham, A.M., Jalgaonkar, S.V., Kaur, H. and Klimov, A., 2012 . Multisite virological influenza surveillance in India: 2004 -2008 . Influenza and other respiratory viruses, 6(3), pp.196-203. 9/2004 -12/2008 3.00% NA-all single 62.30% Taylor, S., Lopez, P., Weckx, L., Borja-Tabora, C., Ulloa-Gutierrez, R., Lazcano-Ponce, E., Kerdpanich, A., Weber, M.A.R., de Los Santos, A.M., Tinoco, J.C. and Safadi, M.A.P., 2017. Respiratory viruses and influenza-like illness: epidemiology and outcomes in children aged 6 months to 10 years in a multi-country population sample. Journal of Infection, 74 (1)